Investigation of cardiorespiratory effects of the selective 5-HT4 agonist BIMU-8 in etorphine-immobilised goats (Capra aegagrus hircus) in a randomized, blinded and controlled trial.

Nadine TodGabrielle StalderHanna RauchStefan BöhmdorferAnna HawHanno GerritsmannJohanna Painer Leith C R Meyer

Published in: The Veterinary record (2021)

Our results indicate that BIMU-8 may be a potential drug candidate for the treatment, or prevention, of etorphine-induced respiratory compromise in immobilised ungulates.

Keyphrases

study protocol
drug induced
high glucose
diabetic rats
body composition
randomized controlled trial
open label
clinical trial
emergency department
oxidative stress
double blind
placebo controlled
human health
adverse drug
replacement therapy